Critical Care

official impact factor 4.60

Letter

Recombinant factor VIIa and factor VIII treatment for acquired factor VIII deficiency: a case of repeated thrombotic endotracheal occlusion in a mechanically ventilated patient

Stefan Lauer1*, Martin Westphal1,2, Lars G Fischer1, Andreas Meißner1, Hugo Van Aken1 and Hendrik Freise1

Author Affiliations

1 Department of Anesthesiology and Intensive Care Medicine, University Hospital Muenster, Albert-Schweitzer-Str. 33, 48149 Muenster, Germany

2 Fresenius Kabi AG, Else-Kröner-Strasse 1, 61352 Bad Homburg, Germany

For all author emails, please log on.

Critical Care 2011, 15:407 doi:10.1186/cc10041

Published: 9 March 2011

First paragraph (this article has no abstract)

Acquired hemophilia A is caused by autoantibodies to coagulation factor VIII (FVIII). Preoperative diagnosis is impaired by the lack of a personal or family history of bleeding episodes. Therefore, surgical procedures can lead to life-threatening hemorrhage [1].